Literature DB >> 3931734

Increased metabolism of arachidonic acid in an immune model of colitis in guinea-pigs.

N K Boughton-Smith, B J Whittle.   

Abstract

Inflammation of the guinea-pig colon was produced by skin sensitization and subsequent intracolonic challenge with the chemical hapten, dinitrochlorobenzene. Metabolism of [14C]-arachidonic acid by homogenates of control colon was very low, although metabolites co-migrating on thin layer chromatography (t.l.c.) with prostaglandin E2 (PGE2), PGF2 alpha, PGD2, 6-keto-PGF1 alpha, thromboxane B2 (TXB2), HHT and 11-, 12-, 15-HETE were formed. There was an overall 3 fold increase in metabolism of [14C]-arachidonic acid by homogenates of inflamed mucosa. The greatest increase in metabolite formation was of PGE2, with smaller increases in HHT, 11-, 12-, 15-HETE, PGD2, TXB2, PGF2 alpha and 6-keto-PGF1 alpha. The formation of these metabolites was inhibited both by indomethacin and the dual pathway inhibitor, BW755C. The formation of immunoreactive PGE2, TXB2 and 6-keto-PGF1 alpha was also increased in homogenates of inflamed guinea-pig colon. The small level of immunoreactive LTB4 detected in control colon was not changed in inflamed colonic tissue. The dinitrochlorobenzene model of colitis offers a means of studying arachidonic acid metabolism in an immune-mediated inflammatory response in intestinal tissue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931734      PMCID: PMC1916693          DOI: 10.1111/j.1476-5381.1985.tb08913.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  FURTHER OBSERVATIONS ON A DELAYED HYPERSENSITIVITY REACTION IN THE GUINEA PIG COLON.

Authors:  R O BICKS; G BROWN; H D HICKEY; E W ROSENBERG
Journal:  Gastroenterology       Date:  1965-04       Impact factor: 22.682

2.  Control of vascular permeability by polymorphonuclear leukocytes in inflammation.

Authors:  C V Wedmore; T J Williams
Journal:  Nature       Date:  1981-02-19       Impact factor: 49.962

3.  Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets.

Authors:  S R Turner; J A Tainer; W S Lynn
Journal:  Nature       Date:  1975-10-23       Impact factor: 49.962

4.  Aspirin-like drugs inhibit arachidonic acid metabolism via lipoxygenase and cyclo-oxygenase in rat neutrophils from carrageenan pleural exudates.

Authors:  M I Siegel; R T McConnell; N A Porter; J L Selph; J F Truax; R Vinegar; P Cuatrecasas
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

5.  On the effect of sulphasalazine on the prostaglandin system and the defective prostaglandin inactivation observed in experimental ulcerative colitis.

Authors:  J R Hoult; P K Moore; A J Marcus; J Watt
Journal:  Agents Actions Suppl       Date:  1979

6.  Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway.

Authors:  M I Siegel; R T McConnell; P Cuatrecasas
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

7.  Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases.

Authors:  P Borgeat; M Hamberg; B Samuelsson
Journal:  J Biol Chem       Date:  1976-12-25       Impact factor: 5.157

8.  A radioimmunoassay for 6-keto-prostaglandin F1alpha.

Authors:  J A Salmon
Journal:  Prostaglandins       Date:  1978-03

9.  Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.

Authors:  D S Rampton; G E Sladen; L J Youlten
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

10.  Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.

Authors:  P Sharon; W F Stenson
Journal:  Gastroenterology       Date:  1985-01       Impact factor: 22.682

View more
  6 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  Presence of immunocytes and sulfidopeptide leukotrienes in the inflamed guinea pig distal colon.

Authors:  D M Hammerbeck; D R Brown
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

3.  Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Model development, histopathology, and effects of sulfasalazine.

Authors:  P Oestreicher; S T Nielsen; K D Rainsford
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

4.  The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat.

Authors:  N K Boughton-Smith; J L Wallace; G P Morris; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

5.  Experimental non-steroidal anti-inflammatory drug-induced enteropathy in the rat: similarities to inflammatory bowel disease and effect of thromboxane synthetase inhibitors.

Authors:  A K Banerjee; T J Peters
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

6.  Selective hyperresponsiveness to ovalbumin-induced epithelial transport in inflamed guinea pig distal colon.

Authors:  D M Hammerbeck; D R Brown
Journal:  Inflammation       Date:  1993-12       Impact factor: 4.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.